Trials / Unknown
UnknownNCT05305833
Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease
Stem Cells Transplantation for Temporomandibular Joint Disease: Phase I/II Study
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- TC Erciyes University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
It will be evaluate the safety of mesenchymal stem cells and adipose tissue derived stromal vascular fraction (SVF) in temporomandibular joint disease cases.
Detailed description
umbilical cord derived mesenchymal stem cells produced under GMP facility in Erciyes University and SVF produced in operation theatre.
Conditions
- Temporomandibular Joint Disorders
- Temporomandibular Disorder
- Temporomandibular Joint Osteoarthritis
- Temporomandibular Joint Pain
- Temporomandibular Joint Effusion
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Stem Cells | ATMP |
Timeline
- Start date
- 2021-10-01
- Primary completion
- 2022-12-01
- Completion
- 2023-12-01
- First posted
- 2022-03-31
- Last updated
- 2022-03-31
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05305833. Inclusion in this directory is not an endorsement.